SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pamela A. Lochhead, Jonathan Clark, Lan-Zhen Wang, Lesley Gilmour, Matthew Squires, Rebecca Gilley, Caroline Foxton, David R. Newell, Stephen R. Wedge, Simon J. Cook, Tumor cells withKRASorBRAFmutations orERK5/MAPK7amplification are not addicted to ERK5 activity for cell proliferation, Cell Cycle, 2016, 15, 4, 506

    CrossRef

  2. 2
    A E S Simões, D M Pereira, S E Gomes, H Brito, T Carvalho, A French, R E Castro, C J Steer, S N Thibodeau, C M P Rodrigues, P M Borralho, Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation, Cell Death and Disease, 2015, 6, 4, e1718

    CrossRef

  3. 3
    Kohichiroh Yasui, Chika Konishi, Yasuyuki Gen, Mio Endo, Osamu Dohi, Akira Tomie, Tomoko Kitaichi, Nobuhisa Yamada, Naoto Iwai, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshio Sumida, Hironori Mitsuyoshi, Shinji Tanaka, Shigeki Arii, Yoshito Itoh, EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma, Cancer Science, 2015, 106, 7
  4. 4
    Paul R. Gavine, Mei Wang, Dehua Yu, Eva Hu, Chunlei Huang, Jenny Xia, Xinying Su, Joan Fan, Tianwei Zhang, Qingqing Ye, Li Zheng, Guanshan Zhu, Ziliang Qian, Qingquan Luo, Ying Yong Hou, Qunsheng Ji, Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma, BMC Cancer, 2015, 15, 1

    CrossRef

  5. 5
    Alessandra Marchetti, Francesca Bisceglia, Angela Cozzolino, Marco Tripodi, New Tools for Molecular Therapy of Hepatocellular Carcinoma, Diseases, 2015, 3, 4, 325

    CrossRef

  6. 6
    Elisabetta Rovida, Giovanni Di Maira, Ignazia Tusa, Stefania Cannito, Claudia Paternostro, Nadia Navari, Elisa Vivoli, Xianming Deng, Nathanael S Gray, Azucena Esparís-Ogando, Ezio David, Atanasio Pandiella, Persio Dello Sbarba, Maurizio Parola, Fabio Marra, The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma, Gut, 2015, 64, 9, 1454

    CrossRef

  7. 7
    松 罗, Review of the ERK5 Signaling Pathway Research, World Journal of Cancer Research, 2014, 04, 04, 41

    CrossRef

  8. 8
    F. Qiu, L. Yang, W. Fang, Y. Li, R. Yang, X. Yang, J. Deng, B. Huang, C. Xie, Y. Zhou, J. Lu, A functional polymorphism in the promoter of ERK5 gene interacts with tobacco smoking to increase the risk of lung cancer in Chinese populations, Mutagenesis, 2013, 28, 5, 561

    CrossRef

  9. 9
    Mio Endo, Kohichiroh Yasui, Yoh Zen, Yasuyuki Gen, Keika Zen, Kazuhiro Tsuji, Osamu Dohi, Hironori Mitsuyoshi, Shinji Tanaka, Masafumi Taniwaki, Yasuni Nakanuma, Shigeki Arii, Toshikazu Yoshikawa, Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma, Liver International, 2013, 33, 1
  10. 10
    Xianming Deng, Jonathan M. Elkins, Jinwei Zhang, Qingkai Yang, Tatiana Erazo, Nestor Gomez, Hwan Geun Choi, Jinhua Wang, Nicolas Dzamko, Jiing-Dwan Lee, Taebo Sim, NamDoo Kim, Dario R. Alessi, Jose M. Lizcano, Stefan Knapp, Nathanael S. Gray, Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones, European Journal of Medicinal Chemistry, 2013, 70, 758

    CrossRef

  11. 11
    Jonathan M. Elkins, Jing Wang, Xianming Deng, Michael J. Pattison, J. Simon C. Arthur, Tatiana Erazo, Nestor Gomez, Jose M. Lizcano, Nathanael S. Gray, Stefan Knapp, X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor, Journal of Medicinal Chemistry, 2013, 56, 11, 4413

    CrossRef

  12. 12
    Rebecca Gilley, Pamela A. Lochhead, Kathryn Balmanno, David Oxley, Jonathan Clark, Simon J. Cook, CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL, Cellular Signalling, 2012, 24, 1, 170

    CrossRef

  13. 13
    M R Cronan, K Nakamura, N L Johnson, D A Granger, B D Cuevas, J-G Wang, N Mackman, J E Scott, H G Dohlman, G L Johnson, Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis, Oncogene, 2012, 31, 34, 3889

    CrossRef

  14. 14
    Pamela A. Lochhead, Rebecca Gilley, Simon J. Cook, ERK5 and its role in tumour development: Figure 1, Biochemical Society Transactions, 2012, 40, 1, 251

    CrossRef

  15. 15
    A K Ramsay, S R C McCracken, M Soofi, J Fleming, A X Yu, I Ahmad, R Morland, L Machesky, C Nixon, D R Edwards, R K Nuttall, M Seywright, R Marquez, E Keller, H Y Leung, ERK5 signalling in prostate cancer promotes an invasive phenotype, British Journal of Cancer, 2011, 104, 4, 664

    CrossRef

  16. 16
    Francisco A. Iñesta-Vaquera, David G. Campbell, Cathy Tournier, Nestor Gómez, Jose M. Lizcano, A. Cuenda, Alternative ERK5 regulation by phosphorylation during the cell cycle, Cellular Signalling, 2010, 22, 12, 1829

    CrossRef

  17. 17
    Kazuhiro Tsuji, Kohichiroh Yasui, Yasuyuki Gen, Mio Endo, Osamu Dohi, Keika Zen, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Masafumi Taniwaki, Shinji Tanaka, Shigeki Arii, Takeshi Okanoue, Toshikazu Yoshikawa, PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma, Cancer Genetics and Cytogenetics, 2010, 198, 2, 118

    CrossRef